PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'nference, inc, Cambridge, United States.\', \'Mayo Clinic, Rochester, United States.\', \'Mayo Clinic Laboratories, Rochester, United States.\', \'Mayo Clinic Platform, Rochester, United States.\', \'Janssen pharmaceutical companies of Johnson & Johnson (J&J), Spring House, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.59209e59209
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 32804081
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all